Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Atara Biotherapeutics (AT20) vs. Competitors

0 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
DE:AT20Atara BiotherapeuticsEUR 7.30EUR 73.29M-7.62-24.74%Moderate BuyUnlock the DE:AT20 analyst price target with TipRanks PremiumDE:AT20Unlock the DE:AT20 top-analyst price target with TipRanks Premium
MGNXMacroGenics$2.20$145.87M-2.7237.50%Moderate BuyUnlock the MGNX analyst price target with TipRanks PremiumDE:AT20 vs MGNXUnlock the MGNX top-analyst price target with TipRanks Premium
ZNTLZentalis Pharmaceuticals$1.70$165.09M-0.8928.79%Moderate BuyUnlock the ZNTL analyst price target with TipRanks PremiumDE:AT20 vs ZNTLUnlock the ZNTL top-analyst price target with TipRanks Premium
SRZNSurrozen$31.61$603.68M-0.72160.81%Strong BuyUnlock the SRZN analyst price target with TipRanks PremiumDE:AT20 vs SRZNUnlock the SRZN top-analyst price target with TipRanks Premium
TCRXTScan Therapeutics$0.16$11.39M-0.18-85.84%HoldUnlock the TCRX analyst price target with TipRanks PremiumDE:AT20 vs TCRXUnlock the TCRX top-analyst price target with TipRanks Premium

Performance Comparison

-100%0%100%200%300%400%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
DE:AT20Atara Biotherapeutics7.30-3.90-34.82%
MGNXMacroGenics2.200.7046.67%
ZNTLZentalis Pharmaceuticals1.700.3727.82%
SRZNSurrozen31.6118.63143.53%
TCRXTScan Therapeutics0.16-0.94-85.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts